CRF CONNECT

Welcome to the Brand page for “CRF CONNECT”, which is offered here for Providing on-line newsletters in the field of structural heart interventions; continuing public service programs in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease produced and distributed over audio, video and internet; production of podcasts in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease; non-downloadable on-line electronic newsletters delivered by e-mail in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease;the mark consists of a red heart with a curved horizontal white line through the middle and an adjoining white line from the top right followed by the letters crf in black and directly underneath a horizontal black line and directly below the line the word connect in black with the nn in connect joined.;newsletters recorded on computer media about interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease; downloadable podcasts in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease; downloadable electronic newsletters in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease; downloadable electronic newsletters delivered by e-mail in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease;transmission of podcasts in the field of interventional cardiology, endovascular medicine, structural heart interventions and structural heart disease;cardiovascular research foundation connect;the color(s) red, white and black is/are claimed as a feature of the mark.;connect;.

Its status is currently believed to be active. Its class is unavailable. “CRF CONNECT” is believed to be currently owned by “Cardiovascular Research Foundation”.